Tvardi Therapeutics, Inc (TVRD) insider trading

Every open-market stock purchase and sale by Tvardi Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • No open-market insider buys on record.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.71 on Jun 11, 2026.

Recent TVRD insider trades

DateInsiderTradeValue
Jun 9, 2026Sujal Shah (Insider)Bought (not open market)—
Jun 9, 2026Michael S Wyzga (Insider)Bought (not open market)—
Jun 9, 2026Susan Shiff Ph.D. (Insider)Bought (not open market)—
Jun 9, 2026Cynthia Smith (Insider)Bought (not open market)—
Jun 9, 2026Wallace L Hall Jr (Insider)Bought (not open market)—
Jan 29, 2026John Saewook Kauh M.D. (C-suite exec)Bought (not open market)—
Jan 29, 2026Imran Nizamudin Alibhai (CEO)Bought (not open market)—
Jan 29, 2026Stephen Paul O'Brien (Insider)Bought (not open market)—
Jan 29, 2026Avi Daniel Conn (CFO)Bought (not open market)—
Dec 16, 2025Imran Nizamudin Alibhai (CEO)Bought (not open market)—
Dec 16, 2025Stephen Paul O'Brien (Insider)Bought (not open market)—
Dec 16, 2025John Saewook Kauh M.D. (C-suite exec)Bought (not open market)—
Dec 16, 2025Avi Daniel Conn (CFO)Bought (not open market)—

Who's trading TVRD

Get free alerts when an insider at Tvardi Therapeutics, Inc files a new trade →